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Abstract
Aerobic glycolysis is a seemingly wasteful mode of ATP production that is seen both in rapidly proliferating mammalian cells
and highly active contracting muscles, but whether there is a common origin for its presence in these widely different
systems is unknown. To study this issue, here we develop a model of human central metabolism that incorporates a solvent
capacity constraint of metabolic enzymes and mitochondria, accounting for their occupied volume densities, while
assuming glucose and/or fatty acid utilization. The model demonstrates that activation of aerobic glycolysis is favored
above a threshold metabolic rate in both rapidly proliferating cells and heavily contracting muscles, because it provides
higher ATP yield per volume density than mitochondrial oxidative phosphorylation. In the case of muscle physiology, the
model also predicts that before the lactate switch, fatty acid oxidation increases, reaches a maximum, and then decreases to
zero with concomitant increase in glucose utilization, in agreement with the empirical evidence. These results are further
corroborated by a larger scale model, including biosynthesis of major cell biomass components. The larger scale model also
predicts that in proliferating cells the lactate switch is accompanied by activation of glutaminolysis, another distinctive
feature of the Warburg effect. In conclusion, intracellular molecular crowding is a fundamental constraint for cell
metabolism in both rapidly proliferating- and non-proliferating cells with high metabolic demand. Addition of this
constraint to metabolic flux balance models can explain several observations of mammalian cell metabolism under steady
state conditions.
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Introduction
The Warburg effect, i.e., glycolysis with lactic acid production
even under normal oxygen saturation (aerobic glycolysis) con-
comitant with mitochondrial oxidative phosphorylation (OxPhos),
is a metabolic phenotype displayed by most cancer cells [1]. The
Warburg effect is also seen in dividing normal lymphocyte [2,3],
endothelial- [4], hair follicle [5] and fibroblast cells [6,7],
indicating that it is inherent to all rapidly proliferating mammalian
cells [8]. Yet, the emergence of this mixed metabolic phenotype is
seemingly counterintuitive, given that glycolysis produces only 2
moles of ATP per mole of glucose, far less than the 32 generated
by OxPhos. Therefore, it has been argued that the Warburg effect
represents a compromise between conflicting metabolic needs, in
which beside the need for ATP the increased production of
glycolytic intermediates is critical to satisfy the need of prolifer-
ating cells for biosynthetic precursor molecules [8], and that the
high level of NADH produced during this enhanced glycolysis can
be most efficiently converted back to NAD+ by the reduction of
pyruvate to lactate [9].
However, anabolic processes may not represent the main factors
underlying the Warburg effect because non-proliferating cells can
also display similar metabolic phenotypes. In particular, the lactate
threshold is a well known feature of muscle physiology, whereby
muscle cells switch to partial anaerobic glucose catabolism when
their contraction activity, and their corresponding ATP demand
for converting chemical energy to mechanical work exceeds
certain intensity [10,11], even when oxygen abundance is not a
limiting factor [12,13,14]. Also, in contrast to proliferating cells,
anabolic processes are downregulated in heavily working muscles
leading to decreased demand for biosynthetic precursors [15].
Taken together, the commonality between the Warburg- and
lactate threshold effects is that the switch from aerobic- to mixed
anaerobic-like metabolism takes place when the ATP production
demand exceeds a threshold, although these demands satisfy
different needs. Thus, in spite of their different routes of utilization,
from the viewpoint of energy metabolism the main challenge is to
understand the differential utilization of catabolic pathways as a
function of the ATP demand. Here we address this fundamental
issue by focusing on the interplay between the catabolism of glucose
and fatty acids by a generic mammalian cell, by extending our
previous model of glucose catabolism within the crowded intracel-
lular milieu of proliferating cells [16]. The similarities and differences
between the metabolisms of these cell types are further investigated
using a larger scale model, accounting for the need of biosynthetic
precursors in proliferating cells and amino acids catabolism.
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Results
Reduced flux balance model of mammalian cell
catabolism
Figure 1 depicts a schematic model of energy metabolism,
including glucose- and fatty acid catabolism with pathway rates fG and
fFA, respectively. The glucose utilization rate (fG) is partitioned into
the anaerobic (fL) and aerobic (fM) glucose catabolism rates, where
fG= fL+fM. Anaerobic glucose metabolism (fL) is decomposed into
glycolysis, converting glucose into pyruvate, and then pyruvate
reduction by lactate dehydrogenase (LDH) in the cytosol, resulting
in the end product lactate that is then excreted to the extracellular
milieu with a yield of YL=2 moles of ATP per mole of glucose.
Aerobic glucose catabolism (fM) is decomposed into the glycolysis
pathway producing pyruvate, the conversion of pyruvate to Acetyl-
CoA, and the oxidation of Acetyl-CoA in the tricarboxylic acid
(TCA) cycle coupled to OxPhos. Glycolysis yields YM=32 moles of
ATP per mole of glucose [17,18], two of which are produced in
glycolysis and the other 30 from the TCA coupled to OxPhos in
mitochondria. In the simplest case scenario, fatty acid (e.g.,
palmitate) catabolism is initiated by the acyl-CoA synthetase
(ACS)-catalyzed activation of fatty acids to form acyl-CoA in the
cytosol, b-oxidation of acyl-CoA to Acetyl-CoA in the mitochon-
dria, and the oxidation of Acetyl-CoA in the TCA cycle coupled to
OxPhos (Fig. 1). Fatty acid activation utilizes 2 ATP, while the
catabolism of acyl-CoA yields YFA+2 ATP, resulting in a yield of YFA
moles of ATP per mole of fatty acid (e.g., Ypalmitate=106). Summing
up these contributions we obtain the rate of ATP production
fATP~YLfLzYMfMzYFAfFA: ð1Þ
Our aim is to determine the optimal flux distribution (fL, fM, fFA)
that provides a required fATP demand given the cell’s metabolic
constraints. Of these, the first metabolic constraint is associated
with the existence of a limited supply of nutrients, here denoted by
fS, to fuel catabolic pathways [19]
fS~fGzfFA~fLzfMzfFA: ð2Þ
This constraint takes into account that the utilization of the
different nutrient pools requires common cellular resources,
including membrane surface for the transporter molecule(s)-
mediated entry of substrates into the cytosol, or cell volume for
intracellular storage pools (e.g., of glycogen). Thus, preference for
utilization of one type of nutrient (or substrate) will limit those
resources for the utilization of other substrates.
The second constraint is the limited solvent capacity for the
allocation of cytosolic enzymes and mitochondria [16]. In our
case, this constraint applies to the cell volume occupied by
glycolytic enzymes, LDH, ACS, and mitochondria. Enzymes
associated with other pathways occupy a fraction of the
intracellular volume as well. Nevertheless, this fraction simply
restricts the amount of the cytoplasmic space available to glycolytic
enzymes, LDH, ACS and mitochondria. More precisely, if VG,
VLDH, VACS and VM are the cell volume occupied by glycolytic
enzymes, LDH, ACS and mitochondria, respectively, then
VG+VLDH+VACS+VM#VATP, where VATP is the total cell volume
available for the allocation of components of the ATP producing
pathways. The occupied volumes VG, VLDH, VACS and VM are
proportional to the enzyme masses MG, MLDH, MACS and the
mitochondrium MM, with VG= vGMG, VLDH= vLDHMLDH, VACS=
vACSMACS and VM= vMMM, where vG, vLDH, vACS and vM are the
specific volumes of glycolytic enzymes, LDH, ACS and mito-
chondria, respectively. In turn, the glycolysis rate [fG], the lactate
excretion rate [2fL], fatty acid activation rate [fFA] and the
mitochondrial ATP production rate [(YM22)fM+(YFA+2) fFA)] are
proportional to the mass of glycolytic enzymes, LDH, ACS and
mitochondria, respectively, with fG= rGMG/V, 2fLDH= rLDHMLDH/
V, fACS= rACSMACS/V and (YM22)fM+(YFA+2)fFA= rMMM/V, where
rG is the glycolysis rate per unit of glycolytic enzyme mass, rL is the
rate of lactate production per mass of LDH, rACS is the rate of fatty
acid activation per mass of ACS, rM is the mitochondrial ATP
production rate per unit of mitochondrial mass, and V is the cell
volume. In these equations the product by the mass and the
division by the cell volume takes into account that the rates r are
commonly reported in the literature per unit of dry weight, while
the pathway rates f are reported per unit of cell volume. Because of
the interdependency of volume, mass and reaction rate, the
volume constraint can be translated to the metabolic constraint
aGzaLDHð ÞfLz aGzaMð ÞfMz aACSzaFAð ÞfFAƒwATP, ð3Þ
where wATP=VATP/V is the total volume fraction of the cell
cytoplasm occupied by glycolytic enzymes, LDH, ACS and
Figure 1. Reduced model of mammalian energy metabolism.
Schematic representation of ATP generation pathways via anaerobic
glucose catabolism (blue arrows, flux fL), aerobic glucose catabolism
(red arrows, flux fM) and aerobic fatty acids catabolism (brown arrows,
flux fFA). The green dotted arrow indicates an expanded variant of the
model where we also take into account a third component of glucose
fate, in which a fraction of the glucose flux is being directed toward the
production of precursor metabolites (flux fP). LDH: lactate dehydroge-
nase, ACS: acyl-CoA synthetase, TCA: tricarboxylic acid cycle and
OxPhos: oxidative phosphorylation.
doi:10.1371/journal.pone.0019538.g001
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mitochondria, and the crowding coefficients [20] aG= vG/rG, aL=2
vLDH/rLDH, aACS= vACS/rACS, aM= (YM22) vM/rM and aFA= (YFA+2)
vM/rM quantify the occupied volume fractions per unit of
glycolysis, lactate excretion, fatty acid activation and glucose and
fatty acid associated mitochondrial respiration rate, respectively.
Using empirical data reported in the literature we have estimated
the crowding coefficients (see Methods). Regarding the glucose
utilization pathways, we obtain aG<0.0027 (min/mM),
aLDH<0.00023 (min/mM) and aM <0.09 (min/mM), indicating
that mitochondria contribute about 5 to 50 times more to
molecular crowding than glycolytic enzymes and LDH. Similarly,
for the fatty acid oxidation pathway, aACS<0.00004–0.0002 (min/
mM) and aFA<0.3 (min/mM) (assuming that palmitate is the fatty
acid substrate and YFA= Ypalpmitate=106) and, therefore, mitochon-
dria contribute at least 1,000 times more toward molecular
crowding than ACS. Taken together these estimates indicate that
the solvent capacity constraint (Equation (3)) can be approximated
by aMfM+aFAfFA#wATP. Note, we cannot exclude the possibility that
under certain physiological conditions aG, aACS, or aLDH may
achieve values comparable to that of aM. Yet, for the sake of
simplicity, we limit our analysis to the scenario supported by the
current empirical evidence.
In our modeling we assume that VATP, rG, rLDH, rACS and rM are
constant parameters that can be obtained from experimental
estimates. Note though, that this is an approximation, as there
may be regulatory mechanisms that under certain environmental
or developmental conditions are capable of altering the amount
of intracellular space allocated to ATP producing pathways and
the activity of glycolytic enzymes, LDH, ACS and mitochondria.
Also, note that our model can be easily modified to investigate
scenarios where one or more pathways are not active due to the
absence of expression of the pathway enzymes, by simply setting
to zero the corresponding pathway rate. For example, the
enzymes involved in fatty acid catabolism are generally not
expressed or are expressed at low levels in cancer cells [21] and in
this case fFA;0.
Given the model (1)–(3), the relevant metabolic optimization
problem can be formulated in two, mathematically equivalent
ways. ATP production maximization: maximize the ATP production
rate fATP given the nutrient supply fS, subject to the solvent
capacity constraint (3). In this case (1) is the optimization
objective while (2) and (3) are constraints. Supply cost minimization:
minimize the nutrient supply fS to satisfy a given ATP production
demand fATP, subject to the solvent capacity constraint. In this
case (2) is the optimization objective while (1) and (3) are
constraints. Furthermore, when solving these optimizations
problems, we can use either fS or fATP as a control parameter
to investigate the existence of metabolic regimes with different
flux distributions (fL, fM, fFA).
Optimal solution for cell catabolism
In the following we discuss the model-predicted utilization of
anaerobic glucose-, and aerobic glucose and fatty acid catabolism
as a function of the ATP demand fATP.
When fFA;0 there are two different regimes (reported in [16],
but as a function of glucose availability fG):
fM~
1
YM
fATP
fL~0
ð4Þ
for fATP,F1, and for fATP$F1
fM&
1
YM
F1
fL&
1
YL
fATP{F1ð Þ
ð5Þ
where
f1~
wATP
aM
ð6Þ
F1~YMf1~
YMwATP
aM
ð7Þ
and the < symbol indicates that we have made use of the fact that
aM..aG, aLDH. This scenario is suitable to model the energy
metabolism of rapidly-proliferating cells, including cancer cells, which
are not using fatty acids as an energy source. The optimal solution is
graphically illustrated in Figure 2a–d. From equation (4) it follows
that at low glucose uptake rates (fG,f1) or low ATP demand
(fATP,F1), ATP is entirely produced by the aerobic pathway and
there is no lactate production (nor excretion). This trend continues up
to a threshold glucose uptake rate f1, or ATP demand F1, when
mitochondria occupy the entire cell volume fraction (VATP) available
for ATP production pathways (Fig. 2b, blue dashed lines, white
background, glucose-limited or low ATP demand regime). Beyond this
threshold value the concentration of mitochondria, and therefore the
rate of ATP production throughOxPhos, cannot be increased further
(Fig. 2b, blue dashed line, gray background). However, equation (5)
predicts that an additional (and increased) glucose uptake may be
diverted toward pathway(s) less efficient in terms of ATP yield per
mole of glucose (Fig. 2a, purple dotted line, gray background, solvent
capacity-limited regime). Indeed, the optimal solution predicts a
metabolic switch, in which glucose uptake rates larger than f1
(defined in equation (6)), or ATP demand above F1 (defined in
equation (7)), leads to a linearly increasing lactate production (Fig. 2d,
red solid line, gray background, solvent capacity-limited regime), and
therefore a component of the ATP production is now derived from
the anaerobic pathway. This behavior was previously reported in Ref.
[16], but now we emphasize that the switch may be equivalently
driven by an increase of glucose uptake or ATP demand.
When fFA is unconstrained, and assuming that YFA significantly
exceeds YM (e.g., Ypalmitate=106 whereas YM=32), there are three
different regimes:
fFA~
1
YFA
fATP
fM~0
fL~0
ð8Þ
for fATP,F0,
fFA&
1
2
YM{2
YMzYFA
F1{fATPð Þ
fM&
1
2
YM{2
YMzYFA
fATP{F0ð Þ
fL~0
ð9Þ
for F0,fATP,F1, and for fATP$F1
The Warburg Effect and the Lactate Threshold
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19538
   
 
 
 
 
 
Figure 2. Catabolic regimes as a function of the ATP demand. Model-predicted fluxes as a function of the ATP demand assuming no limit on
glucose and fatty acid uptake, in the absence (a–d) and presence (e–h) of fatty acid utilization (fFA). Total glucose- (a,e), mitochondrial glucose- (b,f)
and mitochondrial fatty acid utilization (c,g) are shown, together with lactic acid production rates through aerobic glycolysis (d,h). The green dotted
line in a) indicates the correction in the model predictions after considering that a component of the glucose flux is also being directed toward the
production of precursor metabolites (Fig. 1, green dotted line, flux fP).
doi:10.1371/journal.pone.0019538.g002
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fFA~0
fM&
1
YM
F1
fL&
1
YL
fATP{F1ð Þ
ð10Þ
where
F0~
YFAwATP
aFA
ð11Þ
and the < symbol indicates that we have made use of the fact that
aM..aG, aLDH and aFA..aACS. This scenario is suitable for
proliferating cells using both fatty acids and glucose as an energy
source (e.g., prostate cells [21,22]) and also for muscle metabolism.
The optimal solution is graphically illustrated in Figure 2e–h. At
low ATP demand (fATP,F0), it is more efficient to produce ATP
entirely from fatty acids, because this results in a higher ATP yield
than either aerobic- or anaerobic glucose catabolism (Fig. 2g,
white background). Fatty acid uptake increases until the
mitochondrial capacity is saturated for ATP production from
fatty acids, at fATP= F0 (Equation 11). However, because fatty acid
activation consumes 2 ATP molecules whereas aerobic glucose
metabolism produces 2 ATP from the glycolysis step, mitochon-
drial respiration can satisfy a higher ATP demand by switching
from utilization of fatty acids to glucose (Figs. 2f and g, dashed-
grey background). This trend continues until the mitochondrial
capacity is saturated for ATP production from glucose at
fATP=F1.F0 (Equation 7). For ATP demands beyond F1, we
recover the same regimes as when setting fFA;0, with the
components F1 (Fig. 2f, gray background) and fATP-F1 (Fig. 2h,
gray background) from aerobic- and anaerobic glucose metabo-
lism, respectively.
In addition to predict the shape of the plots in Figure 2, our
model also predicts the threshold ATP demands where these
transitions take place. Assuming that mitochondria occupy 7 to
38% of the cytoplasmic volume we obtain the threshold to lactate
excretion F1 = 0.025–0.14 M/min (see Methods). In turn, the
threshold for the transition from fatty acid to glucose can be shown
to be proportional to F1 (from equations 7 and 11),
F0 = [(YFA(YM22))/((YFA+2)YM)]F1, where the coefficient of pro-
portionality is determined by yield coefficients alone. For example,
for palmitate Ypalmitate=106 and we obtain F0<0.92F1, which was
the value used to generate Figure 2d–f.
In proliferating cells, besides generating ATP the glycolysis
pathway also plays a major role in providing precursor metabolites
required for cell biomass production [8]. To investigate how the
results of our analyses on ATP generation and cell catabolism are
affected by accounting for the need of precursor metabolites, in a
variant of our model we also introduce a third component of
glucose fate, in which the glucose flux is also being directed toward
the production of precursor metabolites, denoted by fP (Fig. 1). To
take into consideration that proliferation will demand both
precursor metabolites and energy in the form of ATP, let us
denote by DP(m) and DATP(m) the demand for precursor metabolites
and ATP at a given proliferation rate m. To satisfy these demands
in a stoichiometrically balanced fashion we must thus have
fP= a(m)fATP, where a(m) =DP(m)/DATP(m). This component of the
glycolysis flux should thus be superimposed to that required to
satisfy the ATP demand, as derived in the manuscript. This is
illustrated in the Figure 2a, assuming that a(m) = 0.1 and
independent of the proliferation rate, just for the purpose of
illustration. Importantly, this correction does not modify the results
depicted in Figure 2b,d, plotting the component of glycolysis
diverted towards oxidative phosphorylation and lactate excretion,
respectively. Therefore, accounting for precursor metabolite needs
does not qualitatively change the analytical results for the mode of
ATP production under increasing metabolic demand.
Larger scale flux balance model of mammalian cell
metabolism
The reduced model described above is simple enough to gain a
clear insight on the impact of the solvent capacity constraint on
metabolism. On the other hand, these results need to be tested in
the context of a larger scale model of cell metabolism. To this end,
we expanded our analysis by considering a more detailed model of
mammalian cell metabolism (see Methods). This model accounts
for the catabolism of glucose, fatty acids, and amino acids
(nutrients) and the synthesis of ATP and biomass components. For
simplicity, fatty acids were represented by palmitate alone. We
approximated the effect of the limited solvent capacity by
imposing an upper bound on the mitochondrial respiration rate
fR#fR,max, where fR denotes the respiration rate and fR,max its
maximum achievable value given the solvent capacity constraint.
The latter can be estimated as fR,max=F1/YATP,R based on the
calculations above, where YATP,R is the ATP production yield
relative to the respiration rate, which is about 4.66 [23].
To model the metabolism of proliferating cells we assumed that
the major biomass cell components are produced at a rate
proportional to the proliferation rate. Then we computed the
optimal flux distribution minimizing the sum of nutrient uptake
rates (glucose and amino acids) given a specified proliferation rate.
We observed that the ATP demand, determined as ATP generated
from aerobic glycolysis+mitochondrial OxPhos, increased with
increasing the proliferation rate (Fig. 3a), although with an evident
plateau at intermediate proliferation rates. This plateau was
associated with a transient drop of the glucose uptake rate and a
sudden increase of the glutamine uptake rate at ATP demands close
to the threshold F1 (Fig. 3b), which is in agreement with the result of
a recent study using a genome-scale metabolic model of mammalian
cell metabolism [24]. Overall, the rate of glucose uptake fG, the rate
of full glucose oxidation in the mitochondria YMfM, and the lactate
excretion rate fL manifest similar profiles (Fig. 4a–d) to those
predicted by the reduced model (Fig. 2a–d). The metabolic switch
takes place close to the threshold F1 predicted by the reduced model,
although there is slight shift to the left.
To model the energy demands needed by muscle metabolism
we used as before ATP generation as the metabolic objective and
computed the optimal flux distribution minimizing the nutrients
(glucose, fatty acids and amino acids) uptake given a specified ATP
demand. The resulting glucose uptake, fatty acid uptake, full
glucose oxidation and lactate excretion rates (Fig. 4e–h) manifested
the same qualitative pictures as obtained with the reduced model
(Fig. 2e–h). The metabolic switch takes place close to the threshold
F1 predicted by the reduced model, although there is a slight shift
to the right. We also noted that, in spite of the availability of amino
acids, all energy was generated from fatty acids and glucose.
Taking together these results validate the predictions from the
reduced model in the context of a larger scale model of
mammalian cell metabolism.
Discussion
Empirical evidence indicates that the ATP generating capacity
of OxPhos is saturated at physiological conditions with a high ATP
The Warburg Effect and the Lactate Threshold
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demand. This is unequivocally deduced from the saturation of the
oxygen consumption with increasing the muscle stimulation rate
[25]. However, the precise mechanism behind the OxPhos
saturation has been a topic of continuous debate. Limited oxygen
availability could be an explanation and, indeed, oxygen intake
saturates with increasing the running speed of human subjects
[26]. However, the saturation in oxygen intake can just reflect a
saturation of oxygen demand. Furthermore, experimental reports
indicate that aerobic glycolysis of contracting muscles is indepen-
dent of the oxygenation state [12,13,14]. A second hypothesis is
the saturation of one or more enzymes in the TCA cycle and
electron chain and, indeed, there is a linear correlation between
maximum oxygen consumption and the maximum activity of at
least one TCA cycle enzyme [27]. However, this correlation does
not imply causality.
Here we provide evidence for an unavoidable physical
constraint of biochemical systems as the origin for the activation
of aerobic glycolysis: enzymes occupy a finite volume and,
therefore, there is always an upper limit for the maximum rate
for any metabolic pathway, which is roughly determined by the
achievable maximum concentration of catalytic units, or more
precisely by the solvent capacity constraint [16,20,28,29]. Previous
work [16], together with the results presented here indicates that
the maximum ATP production rate is determined by the
maximum mitochondrial concentration achieved at physiological
conditions. Furthermore, ATP demands beyond that maximum
must be satisfied by the activation of other pathways, e.g., aerobic
glycolysis. Although aerobic glycolysis results in a lower ATP yield
per mole of glucose it can achieve a higher ATP yield per volume
occupied by the associated enzymes.
Importantly, we also show that our main results remain valid
after considering a larger scale model of cell metabolism, including
pathways for the generation of cell biomass components needed
for cell proliferation. The results obtained with this model
recapitulated the reduced model’s predictions, reinforcing the
notion that the ATP demand is the major driver of the Warburg
effect. This observation contradicts the generally accepted notion
that the need for precursor metabolites is the main driving force
behind the Warburg effect in proliferating cells [8]. Moreover,
while the increased need for precursor metabolites does certainly
drive an increasing rate of glucose uptake (as shown analytically in
Fig. 2a), it does not imply any switch-like behavior in the
consumption of glucose, oxidative phosphorylation, and lactate
excretion with increasing the proliferation rate. Also, if the need
for precursor metabolites is really the limiting factor, then it would
make no evolutionary sense to ‘waste’ most of the glycolysis flux
towards the excretion of lactate.
On the other hand, the larger scale model, which accounts for
the potential utilization of glucose and amino acids as well,
uncovers a new observation. It predicts that the lactate excretion
switch in proliferating cells coincides with activation of glutami-
nolysis. This prediction is in agreement with empirical observa-
tions indicating the activation of glutaminolysis as another major
feature of the Warburg effect [30,31,32,33] and with the result of a
recent genome-scale metabolic model of mammalian cell metab-
olism [24]. Our model also predicts that concomitant with the
activation of glutaminolysis, there is a small window of
proliferation rates where the overall ATP production from aerobic
glycolysis and mitochondrial OxPhos remains constant.
For ATP demands below the lactate threshold there are also
differences associated with the use of fatty acids by contracting
muscle cells. We predict that at low ATP demands fatty acids
should be preferred over glucose, because they have a significantly
higher ATP yield per mole of substrate. Thus the rate of fatty acid
oxidation is predicted to increase linearly with increasing the ATP
demand, until the maximum OxPhos capacity is reached. This is
predicted to happen at an ATP demand below the lactate
threshold, because fatty acid catabolism requires first the fatty acid
activation that consumes two ATP, followed by their catabolism in
the mitochondria. In contrast, glycolysis generates two ATP before
being completely oxidized in the mitochondria. This difference
results in a narrow window where OxPhos should shift from fatty
acids to glucose as a substrate, until the lactate threshold is
reached. These theoretical predictions are in perfect agreement
with the experimental evidence that show an increase of fatty acid
utilization with increasing muscle activity, reaching a maximum
before declining completely to zero [34].
Our model has some limitations and cannot explain all aspects
of proliferating normal or tumor cell- or contracting muscle cell
metabolism. First, our analysis is based on a steady state
approximation and, therefore, cannot account for events that
occur on short time scales. For example, our model is useful to
Figure 3. ATP demand in proliferating cells and nutrient
uptake. a) Model-predicted ATP demand as a function of the
proliferation rate (ln2/doubling time), calculated as the sum of the
aerobic glycolysis and OxPhos ATP production rates. At zero
proliferation rate the ATP demand corresponds to the maintenance
needs as indicated by the arrow. Note the plateau at intermediate
proliferation rates. b) Uptake rates of glutamine and glucose as a
function of the ATP demand. It is evident that the plateau in a) and the
transient drop in the glucose uptake rate are both associated with a
sharp increase of the glutamine uptake rate and thus glutaminolysis.
doi:10.1371/journal.pone.0019538.g003
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understand the optimal substrate utilization during steady-state
muscle activity (e.g., running at constant speed) but cannot
describe the transitions that occur during its initiation. Also, we
predict that higher mitochondrial density will increase the
maximum OxPhos capacity, but we cannot explain why the same
tissue type (e.g., cardiac myocytes) from different species contains
 
  
 
  
 
 
Figure 4. Catabolic regimes as a function of the ATP demand (full model). Model-predicted fluxes as a function of the ATP demand
assuming no limit on glucose and fatty acid uptake, in the absence (a–d) and presence (e–h) of fatty acid utilization (fFA). Total glucose- (a,e),
mitochondrial glucose- (b,f) and mitochondrial fatty acid utilization (c,g) are shown, together with lactic acid production rates through aerobic
glycolysis (d,h).
doi:10.1371/journal.pone.0019538.g004
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divergent mitochondrial densities. In addition, our does not
explain why certain tissues (e.g., the brain) evolved not to utilize
fatty acids at all.
In spite of these limitations, providing a common origin for the
Warburg effect in cancer- and in all rapidly proliferating
mammalian cells and the lactate threshold in muscle physiology
significantly increases our understanding of human or mammalian
cell metabolism and opens new research directions. Our modeling
framework could also be used to anticipate how pharmacological
interference with cancer metabolism would affect normal muscle
cell physiology. In turn, we predict the activation of fatty acid
utilization as mechanism for developing resistance to drugs
targeting cancer glucose metabolism.
Materials and Methods
Parameters estimates
aG: The glycolysis rate per total mass of glycolytic enzyme is about
rG=0.29 mmol glucose uptake/min/g at 30uC [35], obtained as
23 mmol/min/mL lactate production rate (Table 4 in Ref. [35]),
divided by 40 mg/mL of total glycolytic protein concentration
(Table 2 in Ref. [35]), and divided by 2 to convert from lactate
production to glucose uptake. The specific volume of glycolytic
enzymes is estimated from the specific volume of globular proteins
0.79 mL/g [36], thus we use vG=0.79 mL/g. Putting these two
values together we obtain aG= vG/rG=0.0027 min/mM. aL: The
rate of lactate production per mass of lactate dehydrogenase is about
rL=7 mmol lactate/min/g at 30uC [35], obtained as 23 mmol/
min/mL lactate production rate (Table 4 in Ref. [35]), divided by
3.2 mg/mL of lactate dehydrogenase concentration (Table 2 in Ref.
[35]). The specific volume of lactate dehydrogenase is estimated
from the specific volume of globular proteins 0.79 mL/g [36], thus
we use vL=0.79 mL/g. Putting these two values together we obtain
aL=2vL/rL=0.00023 min/mM. aM: The mitochondrial rate of
ATP generation per mitochondrial mass is in the range of 0.1–
1.0 mmol ATP/min/g [37,38,39]. We use the maximum value
rM=1.0 mmol ATP/min/g. The mitochondrial specific volume has
been reported to be 3.15 mL/g in mammalian liver [40] and
2.6 mL/g in muscle [41], respectively. We use the average between
these two values vM=2.9 mL/g. Putting these two values together
we obtain aM=32vM/rM=0.09 min/mM and aFA=106vM/
rM=0.3 min/mM (assuming YFA=Ypalmitate=106). The fatty acid
activation rate per unit of acyl-CoA synthase mass is different for
different isoenzymes and substrates. For palmitate, rACS<17.5, 3.47
and 21.1 mmol/min/g, as have been reported for the rat acyl-CoA
synthases ACS1, ASC3 and ASC4, respectively. The specific
volume of acyl-CoA synthase is estimated from the specific volume
of globular proteins 0.79 mL/g [36], thus we use vACS=0.79 mL/g.
Using palmitate as a fatty acid substrate, we obtain aACS= vACS/
rACS<0.00004–0.0002 (min/mM). wATP: The cell volume fraction
occupied by cellular components involved in the generation of ATP
was estimated from the cell volume fraction occupied by
mitochondria. Literature reports for the latter range between 0.07
in some cell lines to 0.38 in muscle cells (Additional file 2 Table S1 in
Ref. [16]). Thus we use wATP=0.07–0.38. f1: Substituting the
experimental estimates aM=0.09 (min/mM), aACS<0.00004–
0.0002 (min/mM), YFA=Ypalmitate=106 and wATP=0.07–0.38 into
Equation 6, 7 and 11 we obtain f1<0.78–4.2 mM/min, F1<0.025–
0.14 M/min and F0<0.025–0.13 M/min, respectively.
Large scale model
The large scale model of cell metabolism included the set of
metabolic reactions listed in the Table S1, which were compiled
from the BiGG database [42]. The biomass components were
specified as their relative abundance in a generic mammalian cell
[43]. In the case of proliferating cells their demand was specified as
their abundance times the proliferation rate m, the latter fixing the
rate of the auxiliary reaction modeling biomass synthesis (Table
S1, Biomass synthesis auxiliary reaction). Two other auxiliary
reactions were added to account for the ATP needs for cell
maintenance [43] and protein turn over [44] (Table S1, ATP
maintenance and Protein turnover reactions). In the case of muscle
cells an auxiliary reaction was added to simulate the ATP demand
of muscle activity (Table S1, ATP synthesis reaction). The optimal
flux distribution was computed solving the linear programming
problem: minimize the sum of nutrient uptake rates (Table S1,
Exchange fluxes, constrained), given a specified metabolic
objective (proliferation rate or ATP demand) and a constraint
on the maximum respiration rate. The respiration rate was
determined as the sum of the cytochrome c oxidase, mitochondrial
complex IV and complex III–IV, catalyzed reactions (Table S1,
reactions 119 and 120). To apply the solvent capacity constraint
we further assumed a mitochondrial volume fraction of wATP=0.1,
which following the derivation above results in F1 = 38 mM/min
and fR,max= F1/YATP,R=8 mM/min, where YATP,R=4.66 is the
ATP yield per respiration rate [23].
Solvent capacity approximations
When making an estimate of the contribution of each pathway
to the crowding of the cell cytoplasm we make use of the total sum
of the enzyme masses that are necessary to maintain the pathway
rate. To be fully precise, that would require the measurement of
enzyme masses and pathway flux or, alternatively, the construction
of a full metabolic model, to account for the metabolite
concentration dependence of reaction rates. In the case of
oxidative phosphorylation the rate of ATP production per
mitochondrial mass is obtained from several experimental reports,
which, because they are direct measurements, they already take
into account all the metabolite regulations in the TCA cycle and
electron transport chain. In the case of glycolysis, we have taken as
a reference an experimental work reporting the glycolysis rate and
the total sum of glycolytic enzymes masses. Thus, in the case of
oxidative phosphorylation and glycolysis, we are not neglecting the
role of metabolite concentrations since these are direct measure-
ments. In the case of lactate excretion and b-oxidation of fatty
acids we do assume that the reaction rates are proportional to the
enzyme masses and neglect the regulation by enzyme concentra-
tions. However, it is important to note that the latter approxima-
tion is only used to reach the conclusion that the contribution of
lactate dehydrogenase and b-oxidation enzymes to molecular
crowding is 10,000 smaller than the contribution of mitochondria.
Therefore, although we have made an approximation, the
profound difference between the estimated contributions to
molecular crowding lead us to completely neglect the contribution
of lactate dehydrogenase and b-oxidation enzymes to molecular
crowding of the cell cytoplasm.
Supporting Information
Table S1 List of reactions included in the larger scale model of
mammalian cell metabolism.
(XLS)
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